Thioguanine is a purine antimetabolite and antineoplastic agent primarily used in the treatment of acute myeloid leukemia and various hematologic malignancies by inhibiting DNA synthesis. To support rigorous… Read more
Thioguanine is a purine antimetabolite and antineoplastic agent primarily used in the treatment of acute myeloid leukemia and various hematologic malignancies by inhibiting DNA synthesis. To support rigorous pharmaceutical analysis, this category provides access to high-quality reference standards of the Thioguanine active pharmaceutical ingredient, alongside a comprehensive selection of pharmacopeial and non-pharmacopeial impurities. Laboratories utilize these compounds, including specific metabolites and stable isotope-labelled standards, to ensure accuracy in impurity profiling and analytical method validation. Whether conducting routine quality control or developing complex assays for drug monitoring, analytical chemists rely on these chemically characterized materials to identify degradation products and quantify active substances effectively. By integrating these precise standards into experimental workflows, researchers maintain compliance with regulatory expectations while ensuring the safety and efficacy of therapeutic formulations throughout the drug development lifecycle.